Hemostats Market Analysis and Scope (2024 to 2031)
Hemostats Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 2.72 Billion |
| Market Size by 2031 | US$ 4.71 Billion |
| Global CAGR (2023 - 2031) | 7.1% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Hemostats Market News and Recent Developments
The Hemostats market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Hemostats market are listed below:
- Ethicon, a Johnson & Johnson MedTech company, announced the approval of ETHIZIATM, an adjunctive hemostat solution which has been clinically proven to achieve sustained hemostasis in difficult to control bleeding situations. Comprised of unique synthetic polymer technology, ETHIZIA Hemostatic Sealing Patch is the first and only hemostatic matrix designed to be equally active and efficacious on both sides. Designed for maximum adaptability, it can be stuffed, rolled, pulled apart, trimmed, and tailored, making it easy to handle in both open and minimally invasive surgeries. (Source: Johnson & Johnson Services, Inc, Press Release, November 2023)
- Baxter International Inc., a global leader in advancing surgical innovation, announced the launch of PERCLOT Absorbable Hemostatic Powder in the US PERCLOT is a passive, absorbable hemostatic powder that is ready to use and designed for patients with intact coagulation to address mild bleeding. (Baxter, Press Release, July 2023)
- Olympus announced the launch of EndoClot Adhesive (ECA), EndoClot Polysaccharide Hemostatic Spray (PHS) and EndoClot Submucosal Injection Solution (SIS) in the Europe, Middle East and Africa (EMEA) region. This innovative portfolio is developed by EndoClot Plus, Inc. (EPI), which expanded its distribution agreement with Olympus from the US to EMEA in December 2022. (Olympus, Press Release, April 2023)
- Medcura, Inc., a commercial-stage life science and medical device company, announced that Walmart.com, one of the world’s largest online retailers, will now be selling the Company’s antibacterial wound gel Rapid-Seal through Walmart.com. Rapid-Seal was cleared by the Food and Drug Administration (FDA) to provide rapid bleeding management and an antibacterial barrier helping to reduce infections. (Medcura, Press Release, December 2022)
- Omni-stat Medical Inc’s parent company, Medtrade Products Ltd is pleased to announce CE certification for its CELOX PPH Uterine Hemostatic Tamponade, a significant and state-of-the-art innovation that provides rapid and effective control of postpartum bleeding, a prevalent and severe complication of childbirth. Gaining accreditation for this game-changing device is a significant medical milestone in the field of obstetrics. (Source: Omni-stat Medical Inc, News, November 2022)
Hemostats Market Report Coverage and Deliverables
The “Hemostats Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Hemostats market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Hemostats market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Hemostats market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Hemostats market
- Detailed company profiles
Get Free Sample For